Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AgfiledCriticalBayer Healthcare Ag
Priority to CU20060145ApriorityCriticalpatent/CU23445A3/es
Publication of CU23445A3publicationCriticalpatent/CU23445A3/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
La presente invención se refiere a un procedimiento para la preparación de 5-cloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morfolinil)fenil]-1,3-oxazolidin-5il}metil)-2-tiofenocarboxamida a partir de 2-[(2S)-2-oxiranilmetil]-1H-isoindol-1,3(2H)-diona, 4-(4-aminofenil)-3-morfolinona y cloruro de 5-clorotiofeno-2-cartbonilo.
CU20060145A2006-07-122006-07-12Procedimiento de preparación
CU23445A3
(es)
Formas de administración farmacéuticas que comprenden 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil) fenil]-1,3-oxazolidin-5-il}metil)-2-tiofencarboxamida
Спосіб одержання поліморфної форми 5-хлор-n-({(5s)-2-okco-3-[4-(3-okco-4-морфолініл)феніл]-1,3-оксазолідин-5-іл}метил)-2-тіофенкарбоксаміду у модифікації іі
PROCESS FOR PREPARING A 5-CHLORINE N - ({(5S) -2-OXO-3- [4- (5,6-DIHYDRO-4H- [1,2,4] TRIAZIN-1-YL) PHENYL] - 1,3-OXAZOLIDIN-5-YL} METHYL-) THIOPHENE-2-CARBOXAMIDE DERIVATIVE AND INTERMEDIATE PRODUCT USED THEREIN